undamentalytics Newsletter

Omada Health, Inc. income statement

In fiscal 2025, Omada Health, Inc. reported revenue of $260m, up 53.2% on the year before, operating income of −$12.0m (a -4.6% margin) and net income of −$12.8m, or −$0.35 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Omada Health, Inc.: income statement, annual
Fiscal year2023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue123170260310
Cost of revenue53678999
Gross profit70103171211
Research and development34364149
Selling and marketing666890104
General and administrative36435258
Operating income−66−44−12−0
Interest expense5530
Income before tax−68−47−134
Income tax0000
Net income−68−47−134
Diluted EPS−$1.90−$1.22−$0.35—
Diluted shares (average)35m39m37m—
EBITDA−62−39−65

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: OMDA vs VMDDCGO vs OMDADLHC vs OMDA

More: Health Care Services stocks compared, Health Care sector, rankings of US companies

Figures from Omada Health, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Omada Health, Inc.